Close

Humana (HUM) Tops Q1 EPS by 26c

May 3, 2017 6:32 AM EDT

Humana (NYSE: HUM) reported Q1 EPS of $2.75, $0.26 better than the analyst estimate of $2.49.

2017 Earnings Guidance

Humana today reaffirmed its recently raised GAAP and Adjusted EPS guidance for the year ending December 31, 2017 (FY17).

A reconciliation of GAAP to Adjusted EPS for the company’s FY17 projections as well as comparable numbers for the year ended December 31, 2016 (FY16) is shown below:

Diluted earnings per common share

FY17Guidance (c)

FY16(d)

GAAP At least $16.91 $4.07

Net (gain) expenses associated with the terminated merger agreement (for FY17, primarily the break-up fee)

(4.36) 0.64
Amortization of identifiable intangibles 0.31 0.32

Beneficial effect of lower effective tax rate in light of pricing and benefit design assumptions associated with the 2017 temporary suspension of the non-deductible health insurance industry fee; excludes Individual Commercial business impact

(2.15) -

Reserve strengthening for the company’s non-strategic closed block of long-term care insurance business (e)

- 2.11

Guaranty fund assessment expense to support the policyholder obligations of Penn Treaty (an unaffiliated long-term care insurance company)

0.24 -
Operating losses associated with the Individual Commercial business given the company’s exit on January 1, 2018 as previously disclosed 0.15 3.78
Adjusted (non-GAAP) – FY17 projected; FY16 as recast

For earnings history and earnings-related data on Humana (HUM) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings, Definitive Agreement